Insurf
File 02 · Public Demo

Watch a denial move beyond the appeal letter.

A recorded walkthrough of the Inveto workbench on synthetic cases — from the denial queue and source-cited packet through physician review, staff-controlled filing, follow-up, and a recorded payer outcome. Below the recording, the extraction and citation pipeline runs live on one disclosed sample.

Recorded walkthrough · End-to-end denial workflowSynthetic case

Run the pipeline live.

This public demo runs one disclosed synthetic case. Every case fact and source passage used by this preview is shown below and fixed for the run. The production workbench accepts real PDFs and requires physician attestation before final export.

Disclosed source set
Synthetic · fixed
Patient
K.M. · GA · synthetic
Coverage
Apex Health · Apex Select Pro · commercial
Request
Pembrolizumab continuation · J9271
Denial
Step therapy
Complete evidence used by this run
  1. Denial letter
    demo-denial-letter.txt

    Apex Health denied J9271 pembrolizumab continuation. Reason: plan requires progression on platinum chemotherapy.

  2. Clinical note
    demo-clinical-note.txt

    Clinical summary: Prior platinum-based chemotherapy was stopped for grade 3 neuropathy and functional decline. Treating clinician assessment: pembrolizumab continuation remains clinically indicated.

  3. Plan policy
    demo-plan-policy.txt

    Prior platinum therapy intolerance may satisfy the step requirement. Expedited review is available when treatment delay risks clinical deterioration.

The demo accepts only this disclosed sample; its evidence cannot be edited or replaced.
What will run
The same extraction and citation code used by the workbench.
Source extraction
Denial, clinical, and policy language stay visible.
Citation validation
Every appeal claim carries source IDs.
Physician gate
Final export stays locked until an authenticated physician signs.
Outcome graph
Staff record payer responses after submission.